| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | — | +79.5% |
| Cost of Revenue | $218K | — | +56.6% |
| Gross Profit | $1.4M | — | +83.8% |
| R&D Expense | $100K | — | +64.4% |
| SG&A Expense | $2.2M | — | -22.8% |
| Operating Income | -$1.7M | — | +24.2% |
| Interest Expense | $26K | — | +1070.7% |
| Net Income | -$1.8M | — | +22.7% |
| EPS (Basic) | -$0.18 | — | +45.5% |
| EPS (Diluted) | -$0.18 | — | +45.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.1M | +42.6% | +253.0% |
| Accounts Receivable | $385K | +96.7% | +58.0% |
| Inventory | $238K | -7.3% | +536.8% |
| Current Assets | $8.1M | +42.0% | +220.5% |
| Total Assets | $8.7M | +36.6% | +188.7% |
| Current Liabilities | $2.8M | +0.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | +23.3% |
| Capital Expenditures | $18K | — | +0.0% |
| Investing Cash Flow | -$18K | — | +0.0% |
| Financing Cash Flow | $3.3M | — | +4886.8% |
| Free Cash Flow | -$1.2M | — | +23.1% |
| +33.9% |
| Total Liabilities | $3.0M | -0.2% | +8.2% |
| Stockholders' Equity | $5.7M | +69.1% | +2123.6% |